Versiti - About Versiti Blood Research Institute
Careers News

About

Since 1947, Versiti has been mission-driven to transform scientific discoveries into life-changing treatments for blood disorders. World-renowned research. Patient-focused impact. Hope through discovery. 

  • One of the world's premier blood health research centers 
  • 30+ leading investigators studying hemophilia, sickle cell disease, blood clotting, and all aspects of blood health
  • Located onthe exceptionalMilwaukeeRegional Medical Center campus
Scientist inspecting a sample under a microscope.

What We Research

  • Transfusion Medicine, Vascular Biology & Cellular Therapy: The biology and pathology of blood vessels,bloodand bloodcells
  • Thrombosis & Hemostasis: DVT, pulmonary embolisms, blood clots, and excessive bleeding
  • Hematopoiesis & Immunology: Blood Cancers,leukemia, lymphoma, immune diseases, and sickle cell disease
  • Translational Hematology: Clinical trials, regenerativemedicine,cells, hemophilia,andvon Willebrand disease
Explore Our Research

Featured News

MACC Fund Commits $11.5 Million To Support Pediactric Cancer Research

MACC Fund Commits $11.5 Million to Propel Pediatric Cancer Research at Versiti Blood Research Institute

Article March 3, 2026

The MACC Fund has committed $11.5 million to advance pediatric cancer research at the Versiti Blood Research Institute, strengthening a long-standing partnership dedicated to improving outcomes for children facing leukemia and other blood disorders.

Read More
Alt

VBRI Senior Investigator Prithu Sundd, PhD, Publishes Breakthrough Study on Lung Thrombosis

Article March 9, 2026

A Nature Communications study led by Prithu Sundd, PhD, shows how a CD39 gene variant may raise lung thrombosis risk in sickle cell disease and could help guide future precision therapies.

Read More
Alt

Eight VBRI Scientists Earn Recognition on Stanford and Elsevier’s Top 2% List

Article March 2, 2026

Eight Versiti Blood Research Institute scientists earned spots on Stanford and Elsevier’s World’s Top 2% Scientists list in the latest update—showing their hematology research is shaping science and patient care worldwide. Meet the investigators behind the impact.

Read More